Table 1 Correlations of sCLU and β-catenin expressions with clinical factors
Parameters | n | sCLU, n (%) | P | β-Catenin, n (%) | P | Coexpression, n (%) | P |
|---|---|---|---|---|---|---|---|
AFP(µg/L) | 0.781 | 0.343 | 0.238 | ||||
< 50 | 36 | 28 (77.78) | 18 (50.00) | 16 (44.44) | |||
≥ 50 | 36 | 27 (75.00) | 22 (61.11) | 21 (58.33) | |||
Portal vein invasion | 0.745 | 0.792 | 0.749 | ||||
With | 7 | 5 (71.43) | 4 (57.14) | 4 (57.14) | |||
Without | 65 | 50 (76.92) | 36 (55.38) | 33 (50.77) | |||
HBsAg | 0.429 | 0.482 | 0.768 | ||||
Positive | 28 | 20 (71.43) | 17 (60.71) | 15 (53.57) | |||
Negative | 44 | 35 (79.55) | 23 (52.27) | 22 (50.00) | |||
Tumor size (cm) | 0.137 | 0.570 | 0.207 | ||||
< 5 | 44 | 31 (70.45) | 23 (52.27) | 20 (45.45) | |||
≥ 5 | 28 | 24 (85.71) | 17 (60.71) | 17 (60.71) | |||
Liver cirrhosis | 0.262 | 0.273 | 0.220 | ||||
With | 54 | 43 (79.63) | 32 (59.26) | 30 (55.56) | |||
Without | 18 | 12 (66.67) | 8 (44.44) | 7 (38.89) | |||
Metastasis | 0.012 | < 0.001 | < 0.001 | ||||
With | 22 | 21 (95.45) | 19 (86.36) | 19 (86.36) | |||
Without | 50 | 34 (68.00) | 21 (42.00) | 18 (36.00) | |||
Differentiation | 0.235 | 0.228 | 0.115 | ||||
Poor | 16 | 14 (87.50) | 11 (68.75) | 11 (68.75) | |||
Others | 56 | 41 (73.21) | 29 (51.78) | 26 (46.43) | |||
Multifocal | 0.235 | 5.500 | 0.019 | 0.032 | |||
Yes | 16 | 14 (87.50) | 13 (81.25) | 12 (75.00) | |||
No | 56 | 41 (73.21) | 27 (48.21) | 25 (44.64) | |||
TNM stage | < 0.001 | 0.001 | < 0.001 | ||||
I and II | 43 | 26 (60.47) | 17 (39.53) | 13 (30.23) | |||
III and IV | 29 | 29 (100.00) | 23 (79.31) | 24 (82.76) |